More Than 10,000 Hernia Mesh Lawsuits Likely To Be Filed Against C.R. Bard in MDL Before First Bellwether Trial Begins

The U.S. District Judge presiding over all federal Bard hernia mesh lawsuits indicates there will likely be at least 10,000 claims brought in the multidistrict litigation (MDL), before the first “bellwether” case goes before a jury in January 2021.

C.R. Bard currently faces more than 8,000 product liability claims filed throughout the federal court system, each involving similar claims that defective polypropylene mesh products were sold in recent years, including Bard Ventralex, Bard Ventralight, Bard Perfix, Bard 3DMax and other hernia patch products.

Plaintiffs allege design problems caused them to experience severe abdominal pain, infections, adhesions, erosion and other complications, often resulting in the need for additional surgery to remove the failed hernia mesh.

Hernia Mesh Lawsuits

Did you or a loved one receive a hernia mesh?

Hernia mesh lawsuits are being filed against Bard, Atrium, Covidien and several other hernia mesh manufacturers over mesh failures resulting in injuries and additional surgery.

Learn More About this Lawsuit See If You Qualify For Compensation

Given common questions of fact and law raised in the complaints, the federal litigation has been centralized before U.S. District Judge Edmund A. Sargus in the Southern District of Ohio, for coordinated discovery and a series of early trial dates designed to help the parties gauge how juries are likely to respond to certain evidence and testimony that will be repeated throughout the claims.

Although the first trial date was originally expected to begin in May 2020, that case has been delayed due to interruptions caused by the COVID-19 pandemic, as the number of new cases filed throughout the federal court system continues to grow.

According to a pretrial order (PDF) issued on August 14, the Court now expects that the number of filed cases will reach about 10,000 by year’s end.

Judge Sargus indicated the first bellwether trial is currently scheduled to begin on January 11, 2021, but that date may be rescheduled, since the Court has another case set to begin in February 2021 which may impact the ability to start the bellwether trial as planned.

The first Bard hernia mesh case to go to before a jury will involve a complaint filed by Steven Johns, who experienced complications with Bard Ventralight ST mesh, which is a type of polypropylene patch involved in a large number of other claims pending in the litigation.

While the outcomes of this jury trial dates will not be binding on other Bard cases, it is expected to have a substantial impact on any hernia patch settlements Bard may offer to avoid the need for thousands of individual trials to be set for trial nationwide in the coming months and years.


Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

More Than 1,200 Valsartan Lawsuits Pending in MDL Over Cancers Caused By Recalled Blood Pressure Drug
More Than 1,200 Valsartan Lawsuits Pending in MDL Over Cancers Caused By Recalled Blood Pressure Drug (Posted today)

Plaintiffs and defendants have briefed the new incoming judge on the status of more than 1,200 Valsartan lawsuits ahead of a meeting later this month, which seeks to begin moving the litigation forward following the retirement of the preceding presiding judge.

BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal
BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal (Posted 4 days ago)

A BioZorb lawsuit has been filed by several breast cancer survivors after the BioZorb implants moved out of place and failed to dissolve int he body, requiring surgical removal.